Clinical trial
Systemic Pharmacokinetics of BOL-303224-A
NCT00407589 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00407589 |
|---|---|
| Title | Systemic Pharmacokinetics of BOL-303224-A |
| Official title | Systemic Pharmacokinetics of BOL-303224-A After Single and Multiple Instillations of BOL-303224-A in Subjects With Suspected Bacterial Conjunctivitis |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Conjunctivitis, Bacterial |
| Intervention type | Drug |
| Interventions | BOL-303224-A |
| Enrollment | 24 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Dec 5, 2006 |
| Last update posted | Dec 9, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: